Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 53, Issue 3
April 2007
Issue Cover
All Issues
ISSN 0009-3157
EISSN 1421-9794

Journal Name Change

Vol. 1-12 (1960-1967) were published under the journal's former title Chemotherapia.

Chemotherapy 2007, Vol. 53, No. 3

Pharmacology

Synergistic Antitumor Activity of Oxaliplatin in Combination with Gemcitabine in Pancreatic Tumor-Bearing Mice
Subject Area: Further Areas , Oncology , Pharmacology
A. Moschidis; A. Papageorgiou; K. Atmatzidis; K. Tsalis; E. Moschidis; J. Livanis; E. Chrysogelou; D. Mourelatos; D. Tsavdaridis; N. Harlaftis
Chemotherapy (2007) 53 (3): 153–159. https://doi.org/10.1159/000100513
View articletitled, Synergistic Antitumor Activity of Oxaliplatin in Combination with Gemcitabine in Pancreatic Tumor-Bearing Mice
Open the PDF for in another window
Induction of Apoptosis by (Z)-Stellettic Acid C, an Acetylenic Acid from the Sponge Stelletta sp., Is Associated with Inhibition of Telomerase Activity in Human Leukemic U937 Cells
Subject Area: Further Areas , Oncology , Pharmacology
Cheol Park; Gi-Young Kim; Won Il Kim; Sang Hoon Hong; Dong Il Park; Nam Deuk Kim; Song-Ja Bae; Jee H. Jung; Yung Hyun Choi
Chemotherapy (2007) 53 (3): 160–168. https://doi.org/10.1159/000100809
View articletitled, Induction of Apoptosis by <em>(Z)</em>-Stellettic Acid C, an Acetylenic Acid from the Sponge <em>Stelletta</em> sp., Is Associated with Inhibition of Telomerase Activity in Human Leukemic U937 Cells
Open the PDF for in another window
Pharmacokinetics of Imipenem in Sheep with Special Reference to Its Hepato-Renal Effects
Subject Area: Further Areas , Oncology , Pharmacology
K. Abo EL-Sooud; W. Khammas; M. Nadir Kadri
Chemotherapy (2007) 53 (3): 169–172. https://doi.org/10.1159/000100810
View articletitled, Pharmacokinetics of Imipenem in Sheep with Special Reference to Its Hepato-Renal Effects
Open the PDF for in another window
Cytotoxicity of Diospyrin and Its Derivatives in Relation to the Generation of Reactive Oxygen Species in Tumour Cells in vitroandin vivo
Subject Area: Further Areas , Oncology , Pharmacology
B. Hazra; M. Das Sarma; B. Kumar; S. Basu; K. Das; B.N. Pandey; K.P. Mishra
Chemotherapy (2007) 53 (3): 173–176. https://doi.org/10.1159/000100514
View articletitled, Cytotoxicity of Diospyrin and Its Derivatives in Relation to the Generation of Reactive Oxygen Species in Tumour Cells in vitroandin vivo
Open the PDF for in another window
Vivotif® – A ‘Magic Shield’ for Protection against Typhoid Fever and Delivery of Heterologous Antigens
Subject Area: Further Areas , Oncology , Pharmacology
Ivaylo Gentschev; Simone Spreng; Heike Sieber; Jose Ures; Fabian Mollet; Andre Collioud; Jon Pearman; Monika E. Griot-Wenk; Joachim Fensterle; Ulf R. Rapp; Werner Goebel; Simon A. Rothen; Guido Dietrich
Chemotherapy (2007) 53 (3): 177–180. https://doi.org/10.1159/000100515
View articletitled, Vivotif® – A ‘Magic Shield’ for Protection against Typhoid Fever and Delivery of Heterologous Antigens
Open the PDF for in another window

Microbiology

Possible Role of sarA in Dehydroepiandrosterone-Mediated Increase in Staphylococcus aureus Resistance to Vancomycin
Subject Area: Further Areas , Oncology , Pharmacology
Balbina J. Plotkin; Monika Konaklieva
Chemotherapy (2007) 53 (3): 181–184. https://doi.org/10.1159/000100863
View articletitled, Possible Role of <em>sarA</em> in Dehydroepiandrosterone-Mediated Increase in <em>Staphylococcus aureus</em> Resistance to Vancomycin
Open the PDF for in another window
Susceptibilities of ESBL-Producing Enterobacteriaceae to Ertapenem, Meropenem and Piperacillin-Tazobactam with and without Clavulanic Acid
Subject Area: Further Areas , Oncology , Pharmacology
David Raveh; Amos M. Yinnon; Ellen Broide; Bernard Rudensky
Chemotherapy (2007) 53 (3): 185–189. https://doi.org/10.1159/000100516
View articletitled, Susceptibilities of ESBL-Producing Enterobacteriaceae to Ertapenem, Meropenem and Piperacillin-Tazobactam with and without Clavulanic Acid
Open the PDF for in another window
Time-Kill Kinetics of Streptococcus pneumoniae with Reduced Susceptibility to Telithromycin
Subject Area: Further Areas , Oncology , Pharmacology
Adnan Al-Lahham; Ralf René Reinert
Chemotherapy (2007) 53 (3): 190–193. https://doi.org/10.1159/000100517
View articletitled, Time-Kill Kinetics of <em>Streptococcus pneumoniae</em> with Reduced Susceptibility to Telithromycin
Open the PDF for in another window
In vitro AN69 and Polysulphone Membrane Permeability to Ceftazidime and in vivo Pharmacokinetics during Continuous Renal Replacement Therapies
Subject Area: Further Areas , Oncology , Pharmacology
Arantxazu Isla; Alicia R. Gascón; Javier Maynar; Alazne Arzuaga; José Antonio Sánchez-Izquierdo; José Luis Pedraz
Chemotherapy (2007) 53 (3): 194–201. https://doi.org/10.1159/000100864
View articletitled, In vitro AN69 and Polysulphone Membrane Permeability to Ceftazidime and in vivo Pharmacokinetics during Continuous Renal Replacement Therapies
Open the PDF for in another window
Role of Ciprofloxacin in Its Synergistic Effect with Fosfomycin on Drug-Resistant Strains of Pseudomonas aeruginosa
Subject Area: Further Areas , Oncology , Pharmacology
Sakuo Yamada; Yukiyoshi Hyo; Sachiyo Ohmori; Masanobu Ohuchi
Chemotherapy (2007) 53 (3): 202–209. https://doi.org/10.1159/000100811
View articletitled, Role of Ciprofloxacin in Its Synergistic Effect with Fosfomycin on Drug-Resistant Strains of <em>Pseudomonas aeruginosa</em>
Open the PDF for in another window

Experimental Chemotherapy

Sulfasalazine-Induced Reduction of Glutathione Levels in Breast Cancer Cells: Enhancement of Growth-Inhibitory Activity of Doxorubicin
Subject Area: Further Areas , Oncology , Pharmacology
Vishal S. Narang; Giovanni M. Pauletti; Peter W. Gout; Donna J. Buckley; Arthur R. Buckley
Chemotherapy (2007) 53 (3): 210–217. https://doi.org/10.1159/000100812
View articletitled, Sulfasalazine-Induced Reduction of Glutathione Levels in Breast Cancer Cells: Enhancement of Growth-Inhibitory Activity of Doxorubicin
Open the PDF for in another window
Mitomycin C and Etoposide in Advanced Colorectal Carcinoma: A Clinical and in vitro Experience That Focuses the Problem of Schedule Dependence in Combination Therapy
Subject Area: Further Areas , Oncology , Pharmacology
P. Seminara; C. Pastore; C. Iascone; F. Cicconetti; G. Nigita; T. Ielapi; F. Franchi
Chemotherapy (2007) 53 (3): 218–225. https://doi.org/10.1159/000100872
View articletitled, Mitomycin C and Etoposide in Advanced Colorectal Carcinoma<span class="subtitle-colon">: </span><span class="subtitle">A Clinical and in vitro Experience That Focuses the Problem of Schedule Dependence in Combination Therapy</span>
Open the PDF for in another window

Clinical Study

Retrospective Evaluation of Sequential Outpatient Chemotherapy for Advanced Gastric Cancer
Subject Area: Further Areas , Oncology , Pharmacology
Seiji Satoh; Kazuhiko Kawashima; Shigemi Matsumoto; Suguru Hasegawa; Hiroshi Okabe; Akinari Nomura; Hiroshi Yoshibayashi; Go Watanabe; Satoshi Nagayama; Masanori Fukushima; Yoshiharu Sakai
Chemotherapy (2007) 53 (3): 226–232. https://doi.org/10.1159/000100865
View articletitled, Retrospective Evaluation of Sequential Outpatient Chemotherapy for Advanced Gastric Cancer
Open the PDF for in another window
Safety and efficacy of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim in Japanese patients with advanced or metastatic urothelial carcinoma
Therapeutic drug monitoring, population pharmacokinetics models and external validation of high-dose methotrexate in pediatric acute lymphoblastic leukemia
Contents Vol. 69, 2024
Time-kill curve analysis of fucoidan combination with conventional antibiotics against biofilms formation of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii clinical isolates
  • Online ISSN 1421-9794
  • Print ISSN 0009-3157
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal